← Evidence map

ArticleInternational immunopharmacology2025

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].

Mehmet Tahir Huyut et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542]. | OpenQuestion